Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company. Shareholders of Kimberly-Clark will own about 54% of ...

From prescription medications that promise life-changing results to vitamin supplements that promote natural wellness, the options are endless — and so are the risks.

And while there are endless beauty blockbuster gifts to peruse, the truth is you don’t need to drop triple digits to snap up ...